Testicular Cancer: When Less is More

被引：1

作者：

Pagliaro, Lance C. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

CURRENT ONCOLOGY REPORTS | 2010年 / 12卷 / 04期

关键词：

Testicular neoplasm; Seminoma; Embryonal carcinoma; Teratoma; Orchiectomy; Radiotherapy; Carboplatin; Cisplatin; Treatment-related malignancy; Male infertility; STAGE-I SEMINOMA; GERM-CELL TUMORS; RISK-ADAPTED MANAGEMENT; LYMPH-NODE DISSECTION; ADJUVANT CHEMOTHERAPY; CISPLATIN CHEMOTHERAPY; TESTIS; SURVEILLANCE; CARBOPLATIN; BLEOMYCIN;

D O I：

10.1007/s11912-010-0105-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Clinical stage I testicular cancer is highly curable. The treatment options include adjuvant chemotherapy or surveillance for most patients, radiotherapy for seminoma, and retroperitoneal lymph node dissection for selected patients with nonseminomatous germ cell tumors. This review discusses the decision points with emphasis on the advantages and disadvantages of each management option.

引用

页码：271 / 277

页数：7

共 28 条

[1] Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German testicular cancer study group [J].

Albers, Peter ;

Siener, Roswitha ;

Krege, Susanne ;

Schmelz, Hans-Uwe ;

Dieckmann, Klaus-Peter ;

Heidenreich, Axel ;

Kwasny, Peter ;

Pechoel, Maik ;

Lehmann, Jan ;

Kliesch, Sabine ;

Koehrmann, Kai-Uwe ;

Fimmers, Rolf ;

Weissbach, Lothar ;

Loy, Volker ;

Wittekind, Christian ;

Hartmann, Michael .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (18) :2966-2972

[2] Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis [J].

Amato, RJ ;

Ro, JY ;

Ayala, AG ;

Swanson, DA .

UROLOGY, 2004, 63 (01) :144-148

[3]

[Anonymous], 1997, J Clin Oncol, V15, P594

[4] Risk-adapted management for patients with clinical stage I seminoma:: The second Spanish germ cell cancer cooperative group study [J].

Aparicio, J ;

Germà, JR ;

del Muro, XG ;

Maroto, P ;

Arranz, JA ;

Sáenz, A ;

Barnadas, A ;

Dorca, J ;

Gumà, J ;

Olmos, D ;

Bastús, R ;

Carles, J ;

Almenar, D ;

Sánchez, M ;

Paz-Ares, L ;

Satrústegui, JJ ;

Mellado, B ;

Balil, A ;

López-Brea, M ;

Sánchez, A .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8717-8723

[5] Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors [J].

Böhlen, D ;

Borner, M ;

Sonntag, RW ;

Fey, MF ;

Studer, UE .

JOURNAL OF UROLOGY, 1999, 161 (04) :1148-1152

[6]

Buchholz TA, 1998, CANCER-AM CANCER SOC, V82, P1126, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1126::AID-CNCR17>3.0.CO

[7]

2-8

[8] Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A medical research council report [J].

Cullen, MH ;

Stenning, SP ;

Parkinson, MC ;

Fossa, SD ;

Kaye, SB ;

Horwich, AH ;

Harland, SJ ;

Williams, MV ;

Jakes, R .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1106-1113

[9]

Daschle T., 2008, CRITICAL WHAT WE CAN, V1st

[10] Controversies in the management of clinical stage I testis cancer [J].

de Wit, Ronald ;

Fizazi, Karim .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) :5482-5492

← 1 2 3 →